UNRESECTABLE PERIHILAR OR DUCTAL CCA

Clinical trials for UNRESECTABLE PERIHILAR OR DUCTAL CCA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE PERIHILAR OR DUCTAL CCA trials appear

Sign up with your email to follow new studies for UNRESECTABLE PERIHILAR OR DUCTAL CCA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Two-Pronged attack on tough bile duct cancer

Disease control Recruiting now

This study is testing whether combining two treatments works better for advanced bile duct cancer that cannot be removed by surgery. Doctors will use a small device to heat and destroy tumor cells inside the bile duct, followed by an immunotherapy drug (durvalumab) plus standard …

Matched conditions: UNRESECTABLE PERIHILAR OR DUCTAL CCA

Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Mar 19, 2026 14:56 UTC

UNRESECTABLE PERIHILAR OR DUCTAL CCA

Get alerted when new UNRESECTABLE PERIHILAR OR DUCTAL CCA trials appear

New Two-Pronged attack on tough bile duct cancer